Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)

Date of Award

02.06.2024

Program

Prevent & Delay

Amount

$55,923,322.00

Term of Grant

85 months

Project Title

The GPPAD-05 Study: Anti-Viral Action against Type 1 diabetes Autoimmunity (AVAnT1A)

Project Description

Funding supports a randomized, placebo-controlled primary prevention clinical trial for type 1 diabetes.